Furthermore, a novel IL-19-targeting nanoparticle (IL-19 antibody conjugated with CHOL-PEG-SPIO-modified nanoparticles, CHOL-PEG-SPIO-IL-19) was developed to detect IL-19 expression levels in human GBM tumors. Here, IL19 is linked to glioblastoma.